Related to Illumina's MiSeq to Support Molecular Profiling Service

• The $1,000 Genome: From Laboratory to Lifestyle
  How we resolve current issues with genetic testing will shape consumer genomics.
  
• Getting Personal: Multigene Testing for Individual Cancer Evaluation
  Scientists find comfort in numbers, using molecular patterns as prognostic markers.
  
• Tumor Cells Back in Circulation for Monitoring Cancer
  With one test on the market, researchers are developing tools that leverage CTCs as biomarkers.
  
• R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine
  Companies are focused on making these platforms smaller and easier to use.
  
• Standardization Key to Taking Next-Generation Sequencing to the Next Level
  As NGS technology makes steady progress with faster and cheaper machines, regulation will have to keep up.
  
• Sequencing Firms Set Up Centers to Advance Genomics Research and Instrument Sales
  Strategy provides a feedback loop to improve instrumentation and develop new applications.
  
• Will Roche Really Drop Illumina and Seek out Another Sequencing Firm?
  Oxford Nanopore and PacBio both have exciting technologies, but Illumina remains market leader.
  
• Illumina, Complete Genomics Prepare for Legal Battle over Sequencing IP
  Illumina filed the case stating that the Complete Genomics Analysis Platform infringes on three of its patents.
  
• Patient Privacy or Scientific Advances: Do They Have to Be Mutually Exclusive?
  Presidential Commission weighs pros and cons of making sequencing data available to researchers and patients.
  
• Harvard Professor Rides Genomics' Third Wave
  New Firm Aims to Advance Personalized Medicine through Precision Diagnostics
  
• Oncogene Addiction: Real or Not?
  Emerging documentation is starting to address that question and increase understanding of process.
  
• One Small Step, No Giant Leap for Privacy
  Privacy and Progress in Whole-Genome Sequencing report lacks implementation framework.
  
• The Long and the Short of DNA Sequencing
  Third-generation sequencers improve on second-generation systems by offering longer reads.
  
• Arrivederci, GINA
  New rules on protecting genetic privacy are under way, as study rekindles debate over sharing vs. protecting data.
  
• Why Biomarker Discovery Is Hard
  Differentiating which markers are in the driver’s seat and which are along for the ride is key.
  
• Genome Testing Reduces Overtreatment
  Study after study has shown that molecular diagnostics can help oncologists more effectively treat patients.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Detecting Acquired Drug Resistance in Cancer
  New methods allow noninvasive analysis in blood plasma.
  
• Your Genes, Your Choice?
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.